JMP Securities analyst Jason Butler maintained a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of $78.00.

JMP Securities analyst Jonathan Wolleben reiterated a Buy rating on Protagonist Therapeutics (PTGX – Research Report) today and set a price ...

Bally’s Corporation (NYSE: BALY; BALY.T) (“Bally’s” or the “Company”) today announced that it has completed the previously ...

JMP Securities updated its outlook on Affirm Holdings Inc. (NASDAQ: NASDAQ:AFRM), increasing the price target to $85 from the ...

JMP Securities reiterated a Market Outperform rating on Sprinklr Inc (NYSE:CXM), with a steady price target of $17.00. The firm's analysts highlighted the company's current performance, which includes ...

Roku Inc. (NASDAQ:ROKU) posted excellent fiscal third-quarter 2024 results, exceeding $1 billion in total net sales for the ...

Mr. Cooper Group Inc. (NASDAQ:COOP – Get Free Report) was the target of unusually large options trading on Wednesday. Traders acquired 10,613 call options on the stock. This is an increase of ...

PJT Partners (NYSE:PJT – Get Free Report) had its price objective boosted by equities researchers at Keefe, Bruyette & Woods from $152.00 to $177.00 in a report issued on Wednesday,Benzinga reports.

Full-year 2024 core EPS reached $3.18, more than double the 2023 results, with a core return on equity of 8.8%. She highlighted that the company has fully restored Property & Casualty profitability, ...

Q1 2025 Earnings Conference Call February 6, 2025 10:00 AM ETCompany ParticipantsKevin Barry - Senior Director, ...